1. A fuzzy logic-based computational method for the repurposing of drugs against COVID-19

Yosef Masoudi-Sobhanzadeh* , Hosein Esmaeili , Ali Masoudi-Nejad*

BioImpacts. 2022;12(4): 315-324. doi: 10.34172/bi.2021.40

PMCID: PMC9376160 PMID: 35975205 Scopus ID: 85137344477

Article

PDF

Full Text

XML

Cited By:

The required data, including proteins and enzymes, are divided into smaller parts and are mined using the existing processors. The proposed method computes the alignment similarity between the existing proteins and SARS-CoV-2’s proteins based on the proposed fuzzy logic system.

Original Article

2. Platinum(IV) compounds as potential drugs: a quantitative structure-activity relationship study

Jurica Novak* , Alena R. Zykova , Vladimir A. Potemkin , Vladimir V. Sharutin, Olga K. Sharutina

Bioimpacts. 2023;13(5): 373-382. doi: 10.34172/bi.2023.24180

PMCID: PMC10509740 PMID: 37736338 Scopus ID: 85172785161

Article

PDF

Suppl 1

Full Text

XML

Cited By:

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons